Pediatric and Neonatal Extracorporeal Life Support Technology Component Utilization: Are US Clinicians Implementing New Technology?

Deborah Reed-Thurston, Feng Qiu, Akif Ündar, Kim Kopenhaver Haidet, Jeffrey Shenberger

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The objective of this investigation is to describe recent changes made in extracorporeal life support (ECLS) technology in the US Postal survey to directors and coordinators of all 125 US ECLS centers identified by Extracorporeal Life Support Organization as of November 2010, with follow-up of nonrespondents. Spearman coefficients were used to correlate the method of updating knowledge of ECLS technology with the likelihood of changing technology, and to correlate decision-making hierarchy with the likelihood of changing equipment. The response rate was 75% representing 34 states, and the majority of respondents were ECLS coordinators (56.6%). Respiratory diagnosis is the predominant indication for ECLS at any age. Over 40% of centers are using a hollow-fiber oxygenator for neonates and 80% of pediatric patients. Roller pumps are used in 70% of neonatal and pediatric ECLS. Forty-two percent of centers changed the oxygenator type within the past 3 years, while 30% changed both the oxygenator and pump. Less than 10% of centers reported problems with either oxygenator or pump in both neonates and pediatric ECLS. Forty-six percent of respondents that changed oxygenators cited that the primary reason for changing was "clinical preference/experience," while the other half was split between "FDA approval" and "Research results." In 40% of centers, a multidisciplinary group made decisions on changing technology. This survey indicates that over one-half of ECLS centers implemented new technology within the past 3 years. Knowledge of ECLS technology and safe operation of ECLS circuit components is essential in preventing some of the mechanical complications.

Original languageEnglish (US)
Pages (from-to)607-615
Number of pages9
JournalArtificial organs
Volume36
Issue number7
DOIs
StatePublished - Jul 1 2012

Fingerprint

Extracorporeal Membrane Oxygenation
Oxygenators
Pediatrics
Technology
Pumps
Newborn Infant
Decision making
Networks (circuits)
Fibers
Half-Life
Decision Making
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

@article{042bfc1164374acea0b43961ce6a02f5,
title = "Pediatric and Neonatal Extracorporeal Life Support Technology Component Utilization: Are US Clinicians Implementing New Technology?",
abstract = "The objective of this investigation is to describe recent changes made in extracorporeal life support (ECLS) technology in the US Postal survey to directors and coordinators of all 125 US ECLS centers identified by Extracorporeal Life Support Organization as of November 2010, with follow-up of nonrespondents. Spearman coefficients were used to correlate the method of updating knowledge of ECLS technology with the likelihood of changing technology, and to correlate decision-making hierarchy with the likelihood of changing equipment. The response rate was 75{\%} representing 34 states, and the majority of respondents were ECLS coordinators (56.6{\%}). Respiratory diagnosis is the predominant indication for ECLS at any age. Over 40{\%} of centers are using a hollow-fiber oxygenator for neonates and 80{\%} of pediatric patients. Roller pumps are used in 70{\%} of neonatal and pediatric ECLS. Forty-two percent of centers changed the oxygenator type within the past 3 years, while 30{\%} changed both the oxygenator and pump. Less than 10{\%} of centers reported problems with either oxygenator or pump in both neonates and pediatric ECLS. Forty-six percent of respondents that changed oxygenators cited that the primary reason for changing was {"}clinical preference/experience,{"} while the other half was split between {"}FDA approval{"} and {"}Research results.{"} In 40{\%} of centers, a multidisciplinary group made decisions on changing technology. This survey indicates that over one-half of ECLS centers implemented new technology within the past 3 years. Knowledge of ECLS technology and safe operation of ECLS circuit components is essential in preventing some of the mechanical complications.",
author = "Deborah Reed-Thurston and Feng Qiu and Akif {\"U}ndar and Haidet, {Kim Kopenhaver} and Jeffrey Shenberger",
year = "2012",
month = "7",
day = "1",
doi = "10.1111/j.1525-1594.2012.01445.x",
language = "English (US)",
volume = "36",
pages = "607--615",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "7",

}

Pediatric and Neonatal Extracorporeal Life Support Technology Component Utilization : Are US Clinicians Implementing New Technology? / Reed-Thurston, Deborah; Qiu, Feng; Ündar, Akif; Haidet, Kim Kopenhaver; Shenberger, Jeffrey.

In: Artificial organs, Vol. 36, No. 7, 01.07.2012, p. 607-615.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pediatric and Neonatal Extracorporeal Life Support Technology Component Utilization

T2 - Are US Clinicians Implementing New Technology?

AU - Reed-Thurston, Deborah

AU - Qiu, Feng

AU - Ündar, Akif

AU - Haidet, Kim Kopenhaver

AU - Shenberger, Jeffrey

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The objective of this investigation is to describe recent changes made in extracorporeal life support (ECLS) technology in the US Postal survey to directors and coordinators of all 125 US ECLS centers identified by Extracorporeal Life Support Organization as of November 2010, with follow-up of nonrespondents. Spearman coefficients were used to correlate the method of updating knowledge of ECLS technology with the likelihood of changing technology, and to correlate decision-making hierarchy with the likelihood of changing equipment. The response rate was 75% representing 34 states, and the majority of respondents were ECLS coordinators (56.6%). Respiratory diagnosis is the predominant indication for ECLS at any age. Over 40% of centers are using a hollow-fiber oxygenator for neonates and 80% of pediatric patients. Roller pumps are used in 70% of neonatal and pediatric ECLS. Forty-two percent of centers changed the oxygenator type within the past 3 years, while 30% changed both the oxygenator and pump. Less than 10% of centers reported problems with either oxygenator or pump in both neonates and pediatric ECLS. Forty-six percent of respondents that changed oxygenators cited that the primary reason for changing was "clinical preference/experience," while the other half was split between "FDA approval" and "Research results." In 40% of centers, a multidisciplinary group made decisions on changing technology. This survey indicates that over one-half of ECLS centers implemented new technology within the past 3 years. Knowledge of ECLS technology and safe operation of ECLS circuit components is essential in preventing some of the mechanical complications.

AB - The objective of this investigation is to describe recent changes made in extracorporeal life support (ECLS) technology in the US Postal survey to directors and coordinators of all 125 US ECLS centers identified by Extracorporeal Life Support Organization as of November 2010, with follow-up of nonrespondents. Spearman coefficients were used to correlate the method of updating knowledge of ECLS technology with the likelihood of changing technology, and to correlate decision-making hierarchy with the likelihood of changing equipment. The response rate was 75% representing 34 states, and the majority of respondents were ECLS coordinators (56.6%). Respiratory diagnosis is the predominant indication for ECLS at any age. Over 40% of centers are using a hollow-fiber oxygenator for neonates and 80% of pediatric patients. Roller pumps are used in 70% of neonatal and pediatric ECLS. Forty-two percent of centers changed the oxygenator type within the past 3 years, while 30% changed both the oxygenator and pump. Less than 10% of centers reported problems with either oxygenator or pump in both neonates and pediatric ECLS. Forty-six percent of respondents that changed oxygenators cited that the primary reason for changing was "clinical preference/experience," while the other half was split between "FDA approval" and "Research results." In 40% of centers, a multidisciplinary group made decisions on changing technology. This survey indicates that over one-half of ECLS centers implemented new technology within the past 3 years. Knowledge of ECLS technology and safe operation of ECLS circuit components is essential in preventing some of the mechanical complications.

UR - http://www.scopus.com/inward/record.url?scp=84863525857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863525857&partnerID=8YFLogxK

U2 - 10.1111/j.1525-1594.2012.01445.x

DO - 10.1111/j.1525-1594.2012.01445.x

M3 - Article

C2 - 22626005

AN - SCOPUS:84863525857

VL - 36

SP - 607

EP - 615

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 7

ER -